News Releases
Astellas to Present at J.P. Morgan Healthcare Conference

TOKYO, Dec. 20, 2017 /PRNewswire/ -- Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, "Astellas" ) today announced that the company's President and CEO Yoshihiko Hatanaka will present at the 36th Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2018 in San Francisco, Calif. The presentation will take place at The Westin St. Francis at 9:30 a.m. PST, with a question and answer session occurring from 10:00 a.m.10:25 a.m. PST.

Astellas is a pharmaceutical company dedicated to improving the health of people around the world. (PRNewsFoto/Astellas Pharma Inc.)

To access a live webcast of the presentation, visit the JP Morgan Web site at https://jpmorgan.metameetings.net/events/healthcare18/sessions/13290-astellas-pharma-inc/webcast.

The materials will also be available on the Astellas website after the presentation:
https://www.astellas.com/en/investors/ir-library.

About Astellas

Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. We focus on Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are also creating new value by combining internal capabilities and external expertise in the medical/healthcare business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at https://www.astellas.com/en.

 

SOURCE Astellas Pharma Inc.

For further information: Media, Tarsis Lopez, 224-205-8833, tarsis.lopez@astellas.com, or Investors, Astellas Pharma Inc., Corporate Communications, +81-3-3244-3201
Copyright © 2005 - 2018 Astellas Pharma US, Inc.